First Mercantile Trust’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$40K Hold
680
0.01% 790
2021
Q2
$59K Sell
680
-83
-11% -$6.69K 0.01% 779
2021
Q1
$63K Sell
763
-131
-15% -$12.6K 0.01% 761
2020
Q4
$81K Buy
+894
New +$55.5K 0.01% 731
2020
Q2
Sell
-5,700
Closed -$127K 887
2020
Q1
$127K Sell
5,700
-250
-4% -$6.32K 0.02% 487
2019
Q4
$116K Sell
5,950
-8,575
-59% -$136K 0.01% 637
2019
Q3
$226K Sell
14,525
-10
-0.1% -$192 0.02% 448
2019
Q2
$295K Buy
14,535
+73
+0.5% +$1.32K 0.03% 320
2019
Q1
$254K Sell
14,462
-665
-4% -$10.5K 0.06% 377
2018
Q4
$194K Sell
15,127
-2,307
-13% -$32.2K 0.05% 436
2018
Q3
$284K Buy
17,434
+4,535
+35% +$53.6K 0.06% 391
2018
Q2
$146K Buy
12,899
+6,863
+114% +$75.6K 0.03% 606
2018
Q1
$59K Buy
+6,036
New +$57.8K 0.01% 727

Other funds holding FATE